FindTrial
Sign In

Surgical innovation for hip bone osteonecrosis

Core Decompression vs core decompression plus intraosseous Ibradonate in early AVN of femoral head in adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/028112
Enrollment
40
Registered
2020-09-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M879- Osteonecrosis, unspecified

Interventions

Intervention1: Core decompression and intraosseous ibandronate: core decompression for avn hip will be done and ibandronate will be instilled through the decompression tract. Control Intervention1: Co

Sponsors

PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Atraumatic AVN of femoral head (Stage 1, 2 Ficat & Arlet)

Exclusion criteria

Exclusion criteria: Traumatic AVN AVN in advanced post collapse stages. Not willing to participate Age 50 years

Design outcomes

Primary

MeasureTime frame
Functional outcome (pain score and modified Harris Hip Score) and radiological outcome(failure: worsening of AVN stage or conversion to hip replacement)Timepoint: Functional outcome (pain score and modified Harris Hip Score) at 6 weeks, 3 months, 6 months, 1 year and 2 years. Radiological outcome(failure: worsening of AVN stage or conversion to hip replacement)will be measured at 1 year and 2 years.—

Secondary

MeasureTime frame
any other complication: idiopathic fractures or infectionsTimepoint: upto 8 weeks—

Countries

India

Contacts

Public ContactPrasoon Kumar

PGIMER

drprasoonksingh@gmail.com9781002142

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026